Outbreaks On Ships
Outbreaks On Ships
Outbreaks On Ships
Interim guidance
24 February 2020
Introduction
This document has been prepared based on current evidence about the transmission of 2019
coronavirus (previously named 2019-nCoV, now designated COVID-19) disease − that is,
human-to-human transmission via respiratory droplets or direct contact with an infected
individual.
It is recommended that this guidance be used with the World Health Organization (WHO)
Handbook for management of public health events on board ships (1).
The target audience for this document is any authority involved in the public health response
to a COVID-19 public health event on board a ship, including International Health Regulations
(IHR) National Focal Points (NFPs), port health authorities, and local, provincial and national
health surveillance and response systems, as well as port operators and ship operators.
1
Prior to boarding
Pre-boarding information
Passengers and crew members should receive information in accordance with WHO’s advice
for international traffic in relation to the outbreak of COVID-19 disease. This advice and
guidance is available at https://www.who.int/health-topics/coronavirus.
Pre-disembarkation information
Until the termination of the COVID-19 public health emergency of international concern is
declared, it is recommended that all passengers and crew members complete their PLF, and
this should be kept on board for at least 1 month after their disembarkation. Information in
the completed PLF should be provided upon request to health authorities to facilitate contact
tracing if a confirmed case is detected after disembarkation or after the voyage has ended.
Pre-boarding screening
Until the termination of the COVID-19 outbreak, passenger ships on an international voyage
are advised to provide passengers with general information on COVID-19 disease and
preventive measures and to implement pre-boarding screening with the purpose of deferring
or rescheduling the boarding of any traveller identified through a questionnaire (Annex 1) as
being a close contact of someone with COVID-19 disease to ensure proper management by
port health authorities.
Education
Ship owners should provide guidance to the crew about how to recognize the signs and
symptoms of COVID-19 disease.
Crew should be reminded of the procedures that are to be followed when a passenger or a
crew member on board displays signs and symptoms indicative of acute respiratory disease.
Country-specific guidance for crew members about prevention measures may be available,
such as that at https://www.cdc.gov/quarantine/maritime/recommendations-for-ships.html
(3).
Additional guidance is available in WHO’s interim guidance about home care for patients with
suspected COVID-19 infection who have mild symptoms and how to manage their contacts (4)
and about the use of medical masks (5).
Healthcare staff on board ships should be informed and updated about the outbreak of
COVID-19 disease and any new evidence and guidance available for healthcare staff.
WHO’s updated information is available at
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance.
2
Managing a suspected case on board a ship
Definition of a suspected case
A suspected case is:
A. a patient with severe acute respiratory infection (that is, fever and cough requiring
admission to hospital) AND with no other aetiology that fully explains the clinical
presentation AND a history of travel to or residence in China or in another country
with established community transmission1 of COVID-19 disease during the 14 days
prior to symptom onset
OR
B. a patient with any acute respiratory illness AND at least one of the following during
the 14 days prior to symptom onset: (a) contact with a confirmed or probable case of
COVID-19 disease or (b) working in or visiting a healthcare facility where patients with
confirmed or probable COVID-19 disease were being treated.
In addition to the medical personnel providing health care, all persons entering the isolation
area should be appropriately trained prior to entering that area, should apply standard
precautions and contact and droplet precautions as described in WHO’s guidance for infection
control (6).
Ship owners must facilitate the use of health measures and provide all relevant public health
information requested by the health authority at the port. Ship operators shall provide to the
port health authorities all essential information (that is, PLFs, the crew list,2 and the passenger
1
Widespread community transmission is defined as being “evidenced by the inability to relate
confirmed cases through a chain of transmission or by increasing positive tests through routine
screening of sentinel samples (i.e., samples unconnected to any known chain of transmission).
2
See the Convention on Facilitation of International Maritime Traffic FAL form 5 at
http://www.imo.org/en/OurWork/Facilitation/FormsCertificates/Pages/Default.aspx, accessed 24
February 2020.
3
list 3 ) to conduct contact tracing when a confirmed case of COVID-19 disease has been
identified on board or when a traveller who has been on board and possibly was exposed
during the voyage is diagnosed as a confirmed case after the end of the voyage.
• When loading patients into the ambulance, transport staff, including medical staff,
should routinely perform hand hygiene and wear a medical mask, eye protection
(goggles or a face shield), a long-sleeved gown and gloves.
• Personal protective equipment (PPE) should be changed after loading each patient
and disposed of appropriately in containers with a lid and in accordance with national
regulations for disposing of infectious waste.
• The driver of the ambulance must remain separate from the cases (keeping at least 1
m distance). No PPE is required if distance can be maintained or a physical separation
exists. If drivers must also help load the patients into the ambulance, they should
follow the PPE recommendations in the previous point.
• Transport vehicles must have as high a volume of air exchange as possible (for
example, by opening the windows).
• Transport staff should frequently clean their hands with an alcohol-based hand rub or
soap and water and ensure that they clean their hands before putting on PPE and
after removing it.
• Ambulances and transport vehicles should be cleaned and disinfected, with particular
attention paid to the areas in contact with the suspected case. Cleaning should be
done with regular household soap or detergent first and then, after rinsing, regular
household disinfectant containing 0.5% sodium hypochlorite (that is, equivalent to
5000 ppm or 1 part bleach to 9 parts water) should be applied.
The IHR NFP will pay attention to IHR Article 43 that concerns additional health measures,
which states that State Parties implementing any additional health measure that significantly
interferes with international traffic (such as refusal of entry or departure of international
travellers and/or ships, or their delay for more than 24 hours) shall provide to WHO the public
health rationale for and relevant scientific information about it.
3
See the Convention on Facilitation of International Maritime Traffic FAL form 6 at
http://www.imo.org/en/OurWork/Facilitation/FormsCertificates/Pages/Default.aspx, accessed 24
February 2020.
4
Managing contacts
In order to avoid delays in implementing health measures, contact tracing should begin
immediately after a suspected case has been identified on board without waiting for
laboratory results. Every effort should be made to minimize the exposure of other travellers
to and on-board environmental exposures of the suspected case, and close contacts must be
separated from other travellers as soon as possible.
All persons on board should be assessed for their risk of exposure and classified either as a
close contact with a high risk of exposure or as having a low risk of exposure.
Until the laboratory result for the suspected case is available, all travellers who fulfil the
definition of a close contact should be asked to complete the PLF (Annex 2) and remain on
board the ship in their cabins or, preferably, at a specially designated onshore facility (if
feasible and when the ship is at the turnaround port where the embarkation or
disembarkation of passengers or discharge or loading of cargo and stores takes place), in
accordance with instructions received from the port health authorities.
If the laboratory result is positive, then all close contacts should be quarantined in specially
designated onshore facilities and not allowed to travel internationally, unless this has been
arranged following WHO’s advice for repatriation, which also discusses quarantine measures
(8). Persons in quarantine who had close contact with a confirmed case should immediately
inform health services if they develop any symptom within 14 days of their last contact with
the confirmed case. If no symptoms appear within 14 days of their last exposure, the contact
is no longer considered to be at risk of developing COVID-19 disease (9). The implementation
of these specific precautions may be modified depending on the risk assessments for
individual cases and their contacts as conducted by the public health authorities.
5
If the laboratory result is positive, then all other travellers who do not fulfil the definition of a
close contact will be considered as having had a low-risk exposure; they should be requested
to complete the PLF with their contact details and the locations where they will be staying for
the following 14 days. The implementation of these precautions may be modified depending
on the risk assessments conducted by the public health authorities. Further instructions may
be given by the health authorities. Travellers considered to have had a low-risk exposure
should be provided with information and advice about (9):
WHO’s guidance about quarantine measures can be found on the web pages about COVID-19
(https://www.who.int/health-topics/coronavirus).
The next voyage can start after thorough cleaning and disinfection have been completed.
Active surveillance should take place on board the ship for the following 14 days. Additionally,
the ship’s owner could explore the possibility of starting the next voyage with a new crew on
board, if this is feasible.
Detailed information about cleaning and disinfecting cabins can be found in WHO’s interim
guidance about home care for patients with suspected COVID-19 infection and how to
manage their contacts (4).
Laundry, food service utensils and waste from the cabins of suspected cases and their contacts
should be handled as if infectious and according to the outbreak management plan provided
on board for other infectious diseases (for example, for norovirus gastroenteritis).
6
It is essential that the ship remains at the port for the time required to thoroughly clean and
disinfect it.
A ship that is considered to have been affected shall cease to be regarded as such when the
port health authority is satisfied with the health measures undertaken and when there are no
conditions on board that could constitute a public health risk (7).
Outbreak investigation
Efforts to control the COVID-19 epidemic focus on containing the disease and preventing new
cases. On board ships it is essential to identify the most likely mode or modes of transmission
and the initial source or sources of the outbreak. Because the outbreak may have international
ramifications, on large ships, including cruise ships that carry nationals from many countries
or areas, the outbreak investigation requires coordinated efforts .
Article 6 of IHR (2005) provides that a State Party shall communicate to WHO all timely,
accurate and sufficiently detailed public health information available to it about the notified
event (such as case definitions, laboratory results, source and type of the risk, number of cases
and deaths, conditions affecting the spread of the disease, and the health measures
employed) and report, when necessary, the difficulties faced in responding to the public
health emergency of international concern and the support needed (7).
Epidemiological investigation
The field investigation team should take all necessary precautions and use PPE appropriately
to avoid becoming infected.
For close contacts, the analyses should consider the following risk factors, where applicable:
who shared cabins, their companions, groups travelling together, and their participation in
onshore activities; the restaurants and bars they attended, seating arrangements at meals
based on reservation lists, buffet service seating locations (schematics); participation in on-
board events or in the ship’s public areas (such as the gym, theatre, cinema, casino, spa,
recreational water facilities); the deck of the cabin where the cases and contacts stayed; and
the fire zone and air handling units. Records to be reviewed and considered in the
investigation are the ship manifest, the ship schematics, cabin reservation lists, activities
reservation lists, records of vomiting incidence, accidental faecal release records for pools,
dining reservation lists, medical logs of passengers and crew with gastrointestinal issues, cabin
plans, the cabin stewards assigned to each cabin and their shifts, and any records about the
demographic characteristics of the travellers. The minimum data requirements that should be
collected are included in the Public Health Passenger/Crew Locator Form (Annex 2).
Environmental investigation
A focused inspection should be conducted to assess whether the isolation procedures and
other measures on board the ship were applied properly, sufficient PPE supplies were
available and staff were trained in the use of PPE. Housekeeping, cleaning and disinfection
procedures (such as protocols, products, concentrations, contact times, use of PPE, mixing
processes) and the frequency of cleaning and disinfection (especially of areas that are
frequently touched) should be checked during the inspection. The focused inspection should
also determine whether any crew might have been working while symptomatic, including food
handlers, housekeeping staff and spa staff.
If feasible, samples from environmental surfaces and materials could be collected and sent to
a laboratory for testing both before and after the cleaning and disinfection procedures are
completed. Staff should be trained to use PPE to avoid becoming infected. The following
7
environmental samples could be collected: surface swabs from cabins where cases stayed,
frequently touched surfaces in public areas, and food preparation areas, including pantries
close to the cabins of affected travellers; air from cabins where cases stayed and medical
rooms where cases were isolated; air from the sewage treatment unit exhaust and engine
exhaust; air ducts; air filters in the air handling units of the cabin; and sewage and recreational
water buffer tanks.
Acknowledgements
WHO gratefully acknowledges the contributions of the WHO Collaborating Centre For The
International Health Regulations: Points Of Entry at the University of Thessaly, Greece, for its
help in developing this document.
8
References
1. Handbook for management of public health events on board ships. Geneva: World
Health Organization; 2016
(https://apps.who.int/iris/bitstream/handle/10665/205796/9789241549462_eng.pdf,
accessed 24 February 2020).
2. Global surveillance for human infection with novel coronavirus (2019-nCoV): interim
guidance, 31 January 2020. Geneva: World Health Organization; 2020 (WHO/2019-
nCoV/SurveillanceGuidance/2020.3; https://apps.who.int/iris/handle/10665/330857,
accessed 24 February 2020).
3. Interim guidance for ships on managing suspected coronavirus disease 2019. Atlanta
(GA): Centers for Disease Control and Prevention; 2020
(https://www.cdc.gov/quarantine/maritime/recommendations-for-ships.html, accessed
24 February 2020).
4. Home care for patients with suspected novel coronavirus (nCoV) infection presenting
with mild symptoms, and management of their contacts: interim guidance, 4 February
2020. Geneva: World Health Organization; 2020 (WHO/nCov/IPC HomeCare/2020.2;
https://apps.who.int/iris/handle/10665/331133, accessed 24 February 2020).
5. Advice on the use of masks in the community, during home care and in health care
settings in the context of the novel coronavirus (2019-nCoV) outbreak: interim guidance,
29 January 2020. Geneva: World Health Organization; 2020
(WHO/nCov/IPC_Masks/2020.1, accessed 24 February 2020)
6. Infection prevention and control during health care when novel coronavirus (nCoV)
infection is suspected: interim guidance, 25 January 2020. Geneva: World Health
Organization; 2020 (https://apps.who.int/iris/handle/10665/330674, accessed 24
February 2020).
7. International health regulations (2005), third edition. Geneva: World Health
Organization; 2016
(http://apps.who.int/iris/bitstream/10665/246107/1/9789241580496-eng.pdf, accessed
24 February 2020).
8. Key considerations for repatriation and quarantine of travellers in relation to the
outbreak of novel coronavirus 2019-nCoV 2020 [updated 11 February 202013/2/2020].
Geneva: World Health Organization; 2020
(https://www.who.int/ith/Repatriation_Quarantine_nCoV-key-considerations_HQ-
final11Feb.pdf, accessed 24 February 2020).
9. Public health management of persons having had contact with novel coronavirus cases
in the European Union. Stockholm: European Centre for Disease Prevention and Control;
2020 (https://www.ecdc.europa.eu/en/publications-data/public-health-management-
persons-having-had-contact-novel-coronavirus-cases, accessed 24 February 2020).
10. International Health Regulations (2005): handbook for inspection of ships and issuance
of ship sanitation certificates. Geneva: World Health Organization; 2011
(WHO/HSE/IHR/LYO/2011.3; https://apps.who.int/iris/handle/10665/44594, accessed
24 February 2020).
9
Annex 1
Sample pre-boarding questionnaire
The questionnaire is to be completed by all adults prior to embarkation.
• _______________________________
Names of all children travelling with you who are under 18 years old:
• _______________________________
• _______________________________
• _______________________________
• _______________________________
Questions
• have you, or has any person listed above, had close contact with anyone diagnosed as
having coronavirus disease (COVID-19)?
• have you, or has any person listed above, provided care for someone with COVID-19
disease or worked with a healthcare worker infected with COVID-19 disease?
• have you, or has any person listed above, visited or stayed in close proximity to
anyone with COVID-19 disease?
• have you, or has any person listed above, worked in close proximity to or shared the
same classroom environment with someone with COVID-19 disease?
• have you, or has any person listed above, travelled with a patient with COVID-19
disease in any kind of conveyance?
• have you, or has any person listed above, lived in the same household as a patient
with COVID-19 disease?
10
Annex 2
Public Health Passenger/Crew Locator Form
11
© World Health Organization 2020. Some rights reserved. This work is available under the
CC BY-NC-SA 3.0 IGO licence.
12